Corcept Therapeutics (0I3Q) Share Forecast & Price Target
0I3Q Analyst Ratings
0I3Q Stock 12 Month Forecast
Average Price Target
$163.75▲(103.49% Upside)Detailed List of Analyst Forecasts
| Analyst Profile | Expert Firm | Price Target | Position | Upside / Downside | Action | Date | Follow | Article |
|---|---|---|---|---|---|---|---|---|
| Edward Nash | Canaccord Genuity | $161 | buy | 100.07%Upside | Reiterated | 10/27/26 | ||
| David Amsellem | Piper Sandler | $165 | buy | 105.05%Upside | Reiterated | 10/27/26 | ||
| Swayampakula Ramakanth | H.C. Wainwright | $165 | buy | 105.05%Upside | Reiterated | 10/01/26 | ||
| Srikripa Devarakonda | Truist Financial | $50→$164 | buy | 103.80%Upside | Initiated | 08/18/26 | ||
| Kalpit Patel | Wolfe Research | $50 | sell | -37.87%Downside | Reiterated | 07/29/26 | ||
| Ashwani Verma | UBS | $72 | buy | -10.53%Downside | Upgraded | 05/13/26 |
| Analyst Profile | Date | Price Target | Position | Upside / Downside | Action | Follow | Article | Expert Firm |
|---|---|---|---|---|---|---|---|---|
| Edward Nash | 10/27/26 | $161 | buy | 100.07%Upside | Reiterated | Canaccord Genuity | ||
| David Amsellem | 10/27/26 | $165 | buy | 105.05%Upside | Reiterated | Piper Sandler | ||
| Swayampakula Ramakanth | 10/01/26 | $165 | buy | 105.05%Upside | Reiterated | H.C. Wainwright | ||
| Srikripa Devarakonda | 08/18/26 | $50→$164 | buy | 103.80%Upside | Initiated | Truist Financial | ||
| Kalpit Patel | 07/29/26 | $50 | sell | -37.87%Downside | Reiterated | Wolfe Research | ||
| Ashwani Verma | 05/13/26 | $72 | buy | -10.53%Downside | Upgraded | UBS |
Best Analysts Covering Corcept Therapeutics
Copying Edward Nash's trades and holding each position for 3 Months would result in 65.71% of your transactions generating a profit, with an average return of +13.91% per trade.
Copying David Amsellem's trades and holding each position for 1 Year would result in 75.86% of your transactions generating a profit, with an average return of +51.67% per trade.
Copying David Amsellem's trades and holding each position for 2 Years would result in 89.66% of your transactions generating a profit, with an average return of +83.66% per trade.
0I3Q Analyst Recommendation Trends
| Rating | May 26 | Jun 26 | Jul 26 | Aug 26 | Sep 26 |
|---|---|---|---|---|---|
| Strong Buy | 5 | 3 | 0 | 0 | 2 |
| Buy | 5 | 10 | 10 | 9 | 8 |
| Hold | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 2 | 2 | 2 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 10 | 15 | 12 | 11 | 10 |
In the current month, 0I3Q has received 10 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. 0I3Q average Analyst price target in the past 3 months is 163.75.
0I3Q Financial Forecast
0I3Q Earnings Forecast
Next quarter’s earnings estimate for 0I3Q is $0.79 with a range of $0.61 to $1.03. The previous quarter’s EPS was $0.36. 0I3Q beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year 0I3Q has Performed in-line its overall industry.
0I3Q Sales Forecast
Next quarter’s sales forecast for 0I3Q is $323.90M with a range of $274.00M to $350.00M. The previous quarter’s sales results were $256.15M. 0I3Q beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year 0I3Q has Performed in-line its overall industry.